Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.

Brenke JK, Popowicz GM, Schorpp K, Rothenaigner I, Roesner M, Meininger I, Kalinski C, Ringelstetter L, R'kyek O, Jürjens G, Vincendeau M, Plettenburg O, Sattler M, Krappmann D, Hadian K.

J Biol Chem. 2018 Aug 24;293(34):13191-13203. doi: 10.1074/jbc.RA118.002649. Epub 2018 Jun 27.

2.

A High-Throughput Screening Strategy for Development of RNF8-Ubc13 Protein-Protein Interaction Inhibitors.

Weber E, Rothenaigner I, Brandner S, Hadian K, Schorpp K.

SLAS Discov. 2017 Mar;22(3):316-323. doi: 10.1177/1087057116681408. Epub 2016 Dec 13.

PMID:
27909234
3.

A Multiplexed High-Content Screening Approach Using the Chromobody Technology to Identify Cell Cycle Modulators in Living Cells.

Schorpp K, Rothenaigner I, Maier J, Traenkle B, Rothbauer U, Hadian K.

J Biomol Screen. 2016 Oct;21(9):965-77. doi: 10.1177/1087057116641935. Epub 2016 Apr 4.

PMID:
27044685
4.

Identification of Small-Molecule Frequent Hitters of Glutathione S-Transferase-Glutathione Interaction.

Brenke JK, Salmina ES, Ringelstetter L, Dornauer S, Kuzikov M, Rothenaigner I, Schorpp K, Giehler F, Gopalakrishnan J, Kieser A, Gul S, Tetko IV, Hadian K.

J Biomol Screen. 2016 Jul;21(6):596-607. doi: 10.1177/1087057116639992. Epub 2016 Apr 4.

PMID:
27044684
5.

A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatment.

Anastasov N, Höfig I, Radulović V, Ströbel S, Salomon M, Lichtenberg J, Rothenaigner I, Hadian K, Kelm JM, Thirion C, Atkinson MJ.

BMC Cancer. 2015 Jun 10;15:466. doi: 10.1186/s12885-015-1481-9.

6.

New small molecules targeting apoptosis and cell viability in osteosarcoma.

Maugg D, Rothenaigner I, Schorpp K, Potukuchi HK, Korsching E, Baumhoer D, Hadian K, Smida J, Nathrath M.

PLoS One. 2015 Jun 3;10(6):e0129058. doi: 10.1371/journal.pone.0129058. eCollection 2015.

7.

Identification of Small-Molecule Frequent Hitters from AlphaScreen High-Throughput Screens.

Schorpp K, Rothenaigner I, Salmina E, Reinshagen J, Low T, Brenke JK, Gopalakrishnan J, Tetko IV, Gul S, Hadian K.

J Biomol Screen. 2014 Jun;19(5):715-26. doi: 10.1177/1087057113516861. Epub 2013 Dec 26.

8.

Clonal analysis by distinct viral vectors identifies bona fide neural stem cells in the adult zebrafish telencephalon and characterizes their division properties and fate.

Rothenaigner I, Krecsmarik M, Hayes JA, Bahn B, Lepier A, Fortin G, Götz M, Jagasia R, Bally-Cuif L.

Development. 2011 Apr;138(8):1459-69. doi: 10.1242/dev.058156. Epub 2011 Mar 2.

9.

Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp).

Vincendeau M, Kramer S, Hadian K, Rothenaigner I, Bell J, Hauck SM, Bickel C, Nagel D, Kremmer E, Werner T, Leib-Mösch C, Brack-Werner R.

AIDS. 2010 Oct 23;24(16):2433-42. doi: 10.1097/QAD.0b013e32833e8758.

PMID:
20827171
10.

Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression.

Rothenaigner I, Kramer S, Meggendorfer M, Rethwilm A, Brack-Werner R.

Gene Ther. 2009 Mar;16(3):349-58. doi: 10.1038/gt.2008.173. Epub 2008 Dec 4.

PMID:
19052634
11.

Long-term HIV-1 infection of neural progenitor populations.

Rothenaigner I, Kramer S, Ziegler M, Wolff H, Kleinschmidt A, Brack-Werner R.

AIDS. 2007 Nov 12;21(17):2271-81.

PMID:
18090275
12.

Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.

Kramer-Hämmerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R.

Virus Res. 2005 Aug;111(2):194-213. Review.

PMID:
15885841

Supplemental Content

Loading ...
Support Center